Connect with us

Hi, what are you looking for?

Investing

MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application submission...

Investing

Investor Insight Syntheia’s innovative conversational AI solution is transforming the face of customer engagement for the B2B market. Backed by a stable financial foundation,...

[doubleoptin_header]







    [doubleoptin_footer]

    World biggest companies